Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Kathleen Claes
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
24
)
Order By :
Title (a-z)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor
01 October 2015 → 30 September 2019
Analysis of chromosomal radiosensitivity/instability in triple negative and/or young breast cancer patients and patients with Fanconi anemia from South Africa
Fellow: Flavia Zita Francies
Funding: Regional and community funding: Special Research Fund
01 January 2024 → 31 December 2024
Cancer predisposition
Funding: Regional and community funding: Special Research Fund
01 July 2022 → 30 June 2025
Cofunding core facility - UGent NGS Core
Funding: Regional and community funding: Special Research Fund
15 April 2020 → 14 April 2021
CONDITIONAL: COvid-19: iNterplay between genetic preDisposITION and immunologicAl Landscape
Funding: Regional and community funding: Special Research Fund
01 January 2019 → 31 December 2019
Development of an in vivo functional assay to determine the pathogenicity of variants in breast cancer genes
Fellow: Jeroen Vierstraete
Funding: Funding by bilateral agreement (private and foundations)
01 January 2021 → 31 December 2024
Diagnosing HEreditary predisposition syndromes for Childhood cancer: Implementation in clinical PRactice (DHECIPR)
Funding: Research Foundation - Flanders (FWO)
01 July 2015 → 30 April 2019
Familial pancreatic cancer: identifying predisposition genes and developing a clinical path for prevention and treatment exploration
Funding: Funding by bilateral agreement (private and foundations)
01 January 2017 → 31 December 2018
HBOC (Hereditary Breast and Ovarian Cancer), a paradigm shift for counseling and treatment of patients with defects in homologous recombination - an explorative study
Funding: Funding by bilateral agreement (private and foundations)
01 November 2019 → 31 October 2024
Heading towards an in vivo predictive test for personalized ovarian cancer treatment: application of novel therapies in zebrafish patient derived xenografts
Fellow: Charlotte Fieuws
Funding: Research Foundation - Flanders (FWO)
15 November 2021 → 14 November 2025
In vivo functional evaluation of unclassified variants, found in the breast cancer gene BRCA2, using CRISPR-mediated genome editing in zebrafish
Fellow: Elyne De Neef
Funding: Regional and community funding: Special Research Fund
01 October 2022 → 30 September 2024
Joint Action on Networks of Expertise
Funding: European funding: various
01 January 2014 → 31 December 2017
miRNAs as alternative second hits and potential therapeutic targets in hereditary breast cancer
Fellow: Mattias Van Heetvelde
Funding: Regional and community funding: IWT/VLAIO
01 October 2023 → 30 September 2027
Multi-omics approach to identify pancreatic cancer biomarkers in liquid biopsies of advanced stage patients by pioneering single cell mass spectrometry of CTCs and (epi)genetics characterization of cfDNA
Funding: Regional and community funding: Special Research Fund
01 April 2010 → 31 March 2013
Next generation sequencing in molecular genetics for hereditary breast cancer, an emerging new strategy
Funding: Research Foundation - Flanders (FWO)
13 July 2017 → 01 October 2018
Pancreatic cancer: hope to improve prognosis through thorough analysis of DNA and RNA biomarkers for detection and therapy monitoring in liquid biopsies
Funding: Funding by bilateral agreement (private and foundations)
01 September 2017 → 31 December 2023
Pancreatic cancer: hope to improve prognosis through thorough analysis of DNA and RNA markers for diagnosis and therapy monitoring in liquid biopsies
Funding: Funding by bilateral agreement (private and foundations)
01 January 2013 → 31 December 2015
Towards improved genetic diagnosis for hereditary breast and ovarian cancer: evolution and challenges
Funding: Funding by bilateral agreement (private and foundations)
01 October 2011 → 30 September 2012
Unraveling genetic mechanisms in early onset breast cancer
Funding: Funding by bilateral agreement (private and foundations)
01 January 2015 → 31 December 2018
Zebrafish as a model system to evaluate the causality of variants of unknown clinical significance in hereditary breast cancer
Funding: Funding by bilateral agreement (private and foundations)
As
Copromotor
01 May 2022 → 30 April 2026
Belgian Genome Biobank
Funding: Research Foundation - Flanders (FWO)
01 January 2015 → 30 September 2021
Personalized functional genomics in Mendelian diseases: from DNA variants to clinical and bioethical implications
Funding: Regional and community funding: Special Research Fund
01 October 2018 → 30 September 2022
RAPID - Radiosensitivity Analysis for patients with a Primary Immunodeficiency Disease
Funding: Research Foundation - Flanders (FWO)
01 May 2024 → 30 April 2028
ThirdGenT: linking third-generation sequencing of (epi)genomes, (epi)transcriptomes and translatomes to life sciences revolutionizes oncology, rare diseases, microbiology, cell and gene technology, developmental and computational biology
Funding: Research Foundation - Flanders (FWO)
As
Researcher
01 January 2018 → 31 December 2021
Immunomonitoring of patients with non-small cell lung carcinoma treated with a tumor mutanome-targeted dendritic cell vaccine
Fellows: Joline Ingels
Funding: Regional and community funding: Special Research Fund